Friday 17 June 2022 12:16 AM 'Lifesaver' breast cancer drug becomes available on the NHS trends now
Friday 17 June 2022 12:16 AM 'Lifesaver' breast cancer drug becomes available on the NHS trends now
'Lifesaver' breast cancer drug which can reduce risk of the disease recurring by a third in some women becomes available on the NHS A drug hailed as a 'breakthrough' for breast cancer victims is now on the NHS Trials show abemaciclib can reduce the risk of one form of the disease by a third The cancer sees 50k diagnosed in England per year, making it the most common
View
comments
A drug hailed as a 'significant breakthrough' for thousands of breast cancer victims was yesterday made available on the NHS.
Trials have shown that abemaciclib can reduce the risk of one form of the disease recurring in some women by a third.
The drug, which is used with hormone therapy, is effective in people who have HR+, HER2- early breast cancer that has a high risk of recurrence and who have had their tumour removed by surgery.
A worldwide trial, led by the Royal Marsden
